Scott M. Wasserman
Private Equity Investor at Frazier Management LLC
Profile
Scott M.
Wasserman is a Venture Partner at Frazier Management LLC since 2023.
Prior to this, he was the Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023 and Vice President & Global Development at Amgen, Inc. from 2015 to 2019.
Wasserman received his undergraduate degree from Haverford College in 1992, his graduate degree from Harvard Medical School in 1997, and his undergraduate degree from Stanford University School of Medicine in 2004.
Scott M. Wasserman active positions
| Companies | Position | Start |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 30/09/2023 |
Former positions of Scott M. Wasserman
| Companies | Position | End |
|---|---|---|
Latigo Biotherapeutics, Inc.
 Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Chief Executive Officer | 31/05/2023 |
| AMGEN INC. | Private Equity Investor | 30/04/2019 |
Training of Scott M. Wasserman
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| Stanford University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |
- Stock Market
- Insiders
- Scott M. Wasserman
